Novel Microfluidic Platforms Enrich Rare Cancer Cells to Study Heterogeneity and Identify Genetic Variants
August 2, 2017 | 11 am to 12 pm EDT
Cancer is comprised of heterogeneous cell populations, and research is increasingly becoming dependent on the ability to isolate rare cells, both enriched populations as well as individual, single cells. Employing advanced molecular cytogenetic technologies to analyze isolated rare cells, such as circulating tumor cells, provides a unique opportunity to interrogate the cancer transcriptome to identify novel genetic variations. These variations could lead to the development of novel cancer biomarkers.
Learning Objectives:
- Introduction to advanced microfluidic technologies to isolate and characterize rare cells
- Applications of NGS approaches to characterize isolated cells
- Importance of characterization and summary of select results
Speakers:
Yixing Wang, Ph.D.
Nallasivam Palanisamy, Ph.D.
Kalyan Handique, Ph.D.
